Related Experiment Video
Updated: May 7, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Thrombin generation in acute cardioembolic and non-cardioembolic ischemic stroke
Elisabeth Rooth1, Piotr Sobocinski-Doliwa, Jovan Antovic
1Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital.
Insights
Thrombin generation is higher in patients with ischemic stroke, particularly cardioembolic stroke, compared to healthy individuals. Further research is needed to understand its long-term prognostic value in stroke patients.
Area of Science:
- Cardiovascular Medicine
- Hematology
- Neurology
Background:
- Increased thrombin generation, measured by Calibrated Automated Thrombogram (CAT), may predict ischemic stroke, especially cardioembolic stroke.
- Limited studies exist on thrombin generation using CAT in patients with manifest ischemic stroke, particularly those with cardioembolic stroke not yet on anticoagulation.
Purpose of the Study:
- To investigate thrombin generation using CAT in patients with acute ischemic stroke or TIA without a history of atrial fibrillation.
- To compare thrombin generation levels between stroke patients and healthy controls.
Main Methods:
- Prospective cohort study of 205 stroke patients (>45 years) without prior atrial fibrillation (AF).
- Patients used a thumb ECG device to detect silent AF.
- Thrombin generation was assessed using CAT at inclusion and 1 month post-stroke.
Main Results:
- Stroke patients exhibited significantly higher peak thrombin concentrations compared to controls (p < 0.0001).
- Thrombin generation levels were highest in patients who were subsequently diagnosed with paroxysmal AF.
- Peak thrombin concentrations varied among stroke patients.
Conclusions:
- Thrombin generation is elevated in patients with acute cardioembolic and non-cardioembolic ischemic stroke/TIA compared to healthy subjects.
- The long-term prognostic significance of thrombin generation in recent ischemic stroke patients warrants further investigation.
Objective:
Increased thrombin generation, as measured by the Calibrated Automated Thrombogram (CAT), has recently been reported to predict ischemic stroke, especially stroke with a cardioembolic source. However, there are few studies on thrombin generation using CAT in patients with manifest ischemic stroke, particularly in patients with cardioembolic stroke not yet on anticoagulation.
Materials And Methods:
Therefore, a prospective cohort study of 205 stroke patients > 45 years of age was performed. They were recruited during their hospital stay or shortly thereafter. Inclusion criteria were ischemic stroke or TIA within two weeks and no atrial fibrillation (AF) in the history or at inclusion. Patients received a thumb ECG device in order to detect silent AF. Blood samples were collected at inclusion and after 1 month. Thrombin generation in plasma after addition of tissue factor was assessed in patients and in healthy controls.
Results:
Mean age of patients was 72 ± 7 years and 43% were females. Peak thrombin concentrations were variable among stroke patients but overall significantly higher at both time points (p < 0.0001) compared to controls, and tended to be highest in patients in whom paroxysmal atrial fibrillation was subsequently documented.
Conclusion:
Thrombin generation in patients with acute cardioembolic and non-cardioembolic schemic stroke/TIA is variable but overall higher compared to healthy subjects. The long-term prognostic value of thrombin generation in patients with a recent ischemic stroke deserves further investigation.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Ischemic Stroke l: Introduction
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Hemorrhagic Stroke ll: Pathophysiology

